![Claus Berner Møller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Claus Berner Møller
Directeur/Membre du Conseil chez
Visiopharm A/S
Profil
Claus Berner Møller is currently a Director at Visiopharm A. He was previously a Chairman at Azanta Danmark A, an Independent Director at Asetek A, and a Vice President at ATP Fondsmaeglerselskab A from 2000 to 2018.
Postes actifs de Claus Berner Møller
| Sociétés | Poste | Début |
|---|---|---|
Visiopharm A/S
 Visiopharm A/S Packaged SoftwareTechnology Services Provides AI-driven precision pathology software services for research, diagnostics and biopharmaceutical services | Directeur/Membre du Conseil | - |
Anciens postes connus de Claus Berner Møller
| Sociétés | Poste | Fin |
|---|---|---|
ATP Fondsmaeglerselskab A/S
 ATP Fondsmaeglerselskab A/S Investment ManagersFinance ATP is an active, long-term, fundamentals-based manager which allocates assets among domestic and foreign bonds, equities, real estate and infrastructure in order to generate as high a return as possible for the pensioners. In addition to ensuring high returns, the firm also invests based on a philosophy of social responsibility in investments. This means that ATP only invests in companies that comply with legislation and international conventions. The way ATP invests includes the following four key elements: (1) hedging of the interest rate risk on pension commitments; (2) effective risk diversification of return on the investment portfolio must be stable and as independent of the business cycle as possible. Therefore, ATP spreads the risk as effectively as possible around four risk factors; (3) focus on strong investment processes; and (4) appropriate level of risk are regularly adjusted in relation to the size of ATP's reserves. | Gestionnaire de Portefeuille-Actions | 17/04/2018 |
| ASETEK A/S | Directeur/Membre du Conseil | - |
Azanta Danmark A/S
 Azanta Danmark A/S Pharmaceuticals: MajorHealth Technology Develops protein therapeutics within orphan oncology and infectious diseases | Président | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
54
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
ATP Fondsmaeglerselskab A/S
ATP Fondsmaeglerselskab A/S Investment ManagersFinance ATP is an active, long-term, fundamentals-based manager which allocates assets among domestic and foreign bonds, equities, real estate and infrastructure in order to generate as high a return as possible for the pensioners. In addition to ensuring high returns, the firm also invests based on a philosophy of social responsibility in investments. This means that ATP only invests in companies that comply with legislation and international conventions. The way ATP invests includes the following four key elements: (1) hedging of the interest rate risk on pension commitments; (2) effective risk diversification of return on the investment portfolio must be stable and as independent of the business cycle as possible. Therefore, ATP spreads the risk as effectively as possible around four risk factors; (3) focus on strong investment processes; and (4) appropriate level of risk are regularly adjusted in relation to the size of ATP's reserves. | Finance |
Azanta Danmark A/S
Azanta Danmark A/S Pharmaceuticals: MajorHealth Technology Develops protein therapeutics within orphan oncology and infectious diseases | Health Technology |
Visiopharm A/S
Visiopharm A/S Packaged SoftwareTechnology Services Provides AI-driven precision pathology software services for research, diagnostics and biopharmaceutical services | Technology Services |
Asetek A/S
 Asetek A/S Engineering & ConstructionIndustrial Services Provides vapor phase & chamber and liquid cooling solutions | Industrial Services |
